[go: up one dir, main page]

AR114693A1 - Vacunas contra infecciones intraabdominales - Google Patents

Vacunas contra infecciones intraabdominales

Info

Publication number
AR114693A1
AR114693A1 ARP190100615A ARP190100615A AR114693A1 AR 114693 A1 AR114693 A1 AR 114693A1 AR P190100615 A ARP190100615 A AR P190100615A AR P190100615 A ARP190100615 A AR P190100615A AR 114693 A1 AR114693 A1 AR 114693A1
Authority
AR
Argentina
Prior art keywords
vaccines against
intraabdominal infections
coli
compositions
intraabdominal
Prior art date
Application number
ARP190100615A
Other languages
English (en)
Inventor
Jan Theunis Poolman
Original Assignee
Janssen Pharmaceuticals Inc
Janssen Vaccines & Prevention Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc, Janssen Vaccines & Prevention Bv filed Critical Janssen Pharmaceuticals Inc
Publication of AR114693A1 publication Critical patent/AR114693A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones y métodos para vacunar contra infecciones intraabdominales provocadas por E. coli. Las composiciones comprenden un polipéptido FimH, uno o más conjugados que comprenden polisacárido de antígenos de E. coli unidos en forma covalente a una proteína transportadora y un adyuvante.
ARP190100615A 2018-03-12 2019-03-12 Vacunas contra infecciones intraabdominales AR114693A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18161252 2018-03-12

Publications (1)

Publication Number Publication Date
AR114693A1 true AR114693A1 (es) 2020-10-07

Family

ID=61832242

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190100615A AR114693A1 (es) 2018-03-12 2019-03-12 Vacunas contra infecciones intraabdominales

Country Status (1)

Country Link
AR (1) AR114693A1 (es)

Similar Documents

Publication Publication Date Title
MX2016012124A (es) Anticuerpos contra glicopeptidos inmunogenicos, composicion que los comprende y usos de estos.
CO2018010458A2 (es) Composiciones y anticuerpos anti-tim-3
EA201890400A1 (ru) Способы и композиции для иммунной защиты против внекишечной патогенной e. coli
CL2021000855A1 (es) Replicones basados en alfavirus para la administración de bioterapias.
CO2021001926A2 (es) Composiciones de escherichia coli y métodos de estas
MX376715B (es) Vacuna contra el virus de la diarrea epidemica porcina.
PE20190207A1 (es) Composiciones que comprenden cepas bacterianas
EA201691478A1 (ru) Новый полисахарид и его применения
AR105470A1 (es) Métodos para inducir una respuesta inmune
MX391989B (es) Conjugados de amatoxina y anticuerpos.
BR112017001588A2 (pt) conjugados de anticorpo/fármaco anti-cdh6
EA201790294A1 (ru) Средства на основе флагеллина и применения, включающие эффективную вакцинацию
MX386692B (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos
MX421186B (es) Constructos de anticuerpos.
MX2020011027A (es) Constructos de anticuerpos biespecíficos trivalentes.
EA201690859A1 (ru) Предотвращение инфекций, вызываемых staphylococcus aureus, гликопротеиновыми вакцинами, синтезированными в escherichia coli
CO2019003949A2 (es) Formulaciones de vacunas de glicoconjugados de expec
MX388647B (es) Compuestos utiles para el tratamiento de una infeccion por mannheimia haemolytica o histophilus somni.
EA202091690A1 (ru) Иммуногенная композиция, содержащая стафилококковые антигены
PL404229A1 (pl) Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
JOP20190038B1 (ar) تركيب اقتراني من السكر المتعدد لكبسولة بكتيريا المكورات الرئوية وبروتين حامل واستخداماته
BR112017005272A2 (pt) uso de cisteamina no tratamento de infecções causadas por leveduras/bolores
EA201591808A1 (ru) Композиции и способы лечения грибковых и бактериальных патогенов
AR114693A1 (es) Vacunas contra infecciones intraabdominales
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo

Legal Events

Date Code Title Description
FB Suspension of granting procedure